ѻý

<ѻý class="page-title">Endocrinology

General Endocrinology

<ѻý class="page-description">

More in General Endocrinology

Hormone Therapy Reduced Insulin Resistance in Healthy Postmenopausal Women

Meta-analysis of 23 randomized trials showed lower HOMA-IR

Sep 14, 2024
TMS over a photo of Hyatt Regency in Chicago, IL.
Steroid Use Tied to Diabetes; Suicide Rates Climbing; Legionnaire's Death Toll Rises

Health news and commentary gathered by ѻý staff

Sep 11, 2024
Morning Break over illustration of a syringe, Covid virus, and DNA helix over a photo of green vegetation.
FreeStyle Libre 3 Sensor Class I Recall; Second OTC CGM Cleared; Weekly Insulin Win

News and commentary from the endocrinology world

Sep 09, 2024
Endo Break over a computer rendering of a man with illustrated body organs.
Early Parathyroidectomy No Boon for Preventing Depression

But neurocognitive effects of surgery may be more subtle than a clinical depression diagnosis

Sep 06, 2024
A computer rendering of the thyroid with the parathyroid glands highlighted.
Meat Types and T2D; Semaglutide in Heart Failure; Acromegaly at the Paralympics

News and commentary from the endocrinology world

Sep 03, 2024
Endo Break over a computer rendering of a man with illustrated body organs.
Novel Drug Reduced Triglycerides, Risk of Pancreatitis in Persistent Chylomicronemia

Benefits seen in patients with and without a genetic diagnosis

Sep 03, 2024
ESC over a photo of ExCeL London conference and exhibition center.
T1D Stem Cell Success Story; Lilly's Discount Tirzepatide Vials; Stelo Now Available

News and commentary from the endocrinology world

Aug 27, 2024
Endo Break over a computer rendering of a man with illustrated body organs.
Zepbound Can Prevent Diabetes; Menopause and Cognition; Tandem's Insulin Pump Update

News and commentary from the endocrinology world

Aug 20, 2024
Endo Break over a computer rendering of a man with illustrated body organs.
Disposable CGM Approved; Mounjaro Tied to Reduced Mortality; Benefits of Lignins

News and commentary from the endocrinology world

Aug 13, 2024
Endo Break over a computer rendering of a man with illustrated body organs.
FDA OKs Once-Daily Injection for Hypoparathyroidism

Palopegteriparatide will be the only drug targeting underlying cause of rare endocrine disorder

Aug 12, 2024
FDA APPROVED palopegteriparatide (Yorvipath) over a computer rendering of the thyroid gland.
Eating Disorders After GLP-1s? Tirzepatide for Heart Failure; Soda Taxes and BMI

News and commentary from the endocrinology world

Aug 06, 2024
Endo Break over a computer rendering of a man with illustrated body organs.
New Firearm Injury Numbers; Another Indication for Semaglutide?

Also in TTHealthWatch: bilateral mastectomy for breast cancer

Aug 03, 2024
TTUHSC EL PASO HEALTHWATCH with their logo and photos of Rick Lange, MD, and Elizabeth Tracey
How Good Is Wegovy's Heart Benefit?

Experts put SELECT trial findings in context

Aug 01, 2024
A close up photo of two semaglutide (Wegovy) injection pens.
Faulty FreeStyle Libre 3 Sensors; Endocrine Society Merger; More Levemir Pushback

News and commentary from the endocrinology world

Jul 30, 2024
Endo Break over a computer rendering of a man with illustrated body organs.
More in General Endocrinology

1.00 CME Credits
Navigating Cardiovascular Risk: The Critical Role of Lipoprotein(a) Screening and Treatment

0.50 CME Credits
Breakthroughs in Severe Hypertriglyceridemia and Familial Chylomicronemia Syndrome Management: Key Findings From ACC 2024

0.50 CME Credits
Adjuvant Endocrine Therapy in HR+ Breast Cancer: Enhancing Quality Care and Patient Outcomes

1.00 CME Credits
Evidence-Based Strategies and Emerging Approaches for Individualizing Obesity Care

0.25 CME Credits
Applying the Latest Evidence to Overcome Endocrine Resistance in HR+/HER2- Breast Cancer

1.00 CME Credits
Leveraging Continuous Glucose Monitoring (CGM) to Improve Outcomes in Type 2 Diabetes

1.50 CME Credits
Breaking Barriers in Obesity Management: Adopting a Holistic Approach to Optimize Health Outcomes

0.50 CME Credits
Cutting-Edge Treatment Approaches for Patients With T1D and Impaired Awareness of Hypoglycemia (IAH)